Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.09 trillion and total revenue of $110.26 billion.
Market Cap
1.09T
Revenue
110.26B
Profits
-40.73B
PE Ratio
n/a
Profit Margin
-36.94%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.16B | -0.73% | 389,068 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.35B | 1.76% | 326,965 | 14.34B |
| 3 | ARGX | argenx SE | 44.16B | 1.20% | 319,389 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.26B | -0.63% | 583,188 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.06B | -1.03% | 107,126 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.41B | 0.67% | 864,822 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 26.39B | 0.74% | 1,505,833 | 2.38B |
| 8 | BNTX | BioNTech SE | 25.35B | -0.45% | 560,958 | 3.70B |
| 9 | MRNA | Moderna, Inc. | 21.14B | 1.90% | 7,294,226 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.84B | 1.18% | 3,759,672 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.46B | -0.19% | 736,618 | - |
| 12 | INCY | Incyte Corporation | 19.12B | 0.15% | 611,333 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.50B | -1.02% | 835,978 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.69B | -0.54% | 470,906 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 12.60B | -0.54% | 862,878 | 502.08M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 12.30B | 0.53% | 1,991,834 | 943.71M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.02B | 2.58% | 1,433,715 | - |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.59B | -1.37% | 497,339 | 3.22B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.26B | 0.46% | 322,039 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.79B | -0.04% | 1,556,216 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.75B | -1.80% | 168,809 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 8.49B | -0.49% | 436,688 | 6.23M |
| 23 | TECH | Bio-Techne Corporation | 8.41B | -0.24% | 1,189,174 | 1.22B |
| 24 | IBRX | ImmunityBio, Inc. | 8.35B | -6.34% | 18,030,997 | 113.29M |
| 25 | PCVX | Vaxcyte, Inc. | 8.35B | -2.18% | 502,410 | - |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.34B | 0.41% | 212,157 | 638.50M |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.21B | -2.02% | 1,248,510 | 1.09B |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 8.17B | -5.53% | 296,602 | 7.46M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 7.96B | 0.07% | 741,870 | 1.40B |
| 30 | NUVL | Nuvalent, Inc. | 7.88B | 0.88% | 273,120 | - |
| 31 | CYTK | Cytokinetics, Incorporated | 7.55B | 1.52% | 1,451,977 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.48B | 0.80% | 121,352 | 389.13M |
| 33 | BLTE | Belite Bio, Inc | 6.83B | 0.20% | 74,428 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.74B | -1.11% | 217,476 | 39.21M |
| 35 | ACLX | Arcellx, Inc. | 6.69B | 0.13% | 1,021,046 | 22.29M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.22B | -2.57% | 272,950 | 189.76M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.08B | 3.43% | 271,958 | 46.02M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.86B | -1.79% | 686,033 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.59B | 7.42% | 1,190,817 | 1.73B |
| 40 | CRSP | CRISPR Therapeutics AG | 5.54B | 2.12% | 677,998 | 3.51M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.25B | 0.88% | 571,667 | 521.31M |
| 42 | IMVT | Immunovant, Inc. | 5.25B | -3.26% | 759,647 | - |
| 43 | CAI | Caris Life Sciences, Inc. | 5.21B | -0.86% | 1,451,795 | 812.03M |
| 44 | CELC | Celcuity Inc. | 5.16B | -2.95% | 636,804 | - |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 5.12B | 46.72% | 9,492,971 | 7.50M |
| 46 | CGON | CG Oncology, Inc. | 5.10B | -2.38% | 716,604 | 4.04M |
| 47 | APGE | Apogee Therapeutics, Inc. | 5.07B | 0.78% | 454,964 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.98B | -4.37% | 396,397 | - |
| 49 | ERAS | Erasca, Inc. | 4.75B | -0.84% | 2,291,474 | - |
| 50 | TERN | Terns Pharmaceuticals, Inc. | 4.66B | 0.07% | 680,216 | - |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.50B | -0.03% | 1,422,801 | 634.21M |
| 52 | TGTX | TG Therapeutics, Inc. | 4.22B | -2.29% | 858,469 | 616.29M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.09B | 1.50% | 83,633 | 268.09M |
| 54 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.97B | -0.71% | 647,345 | 7.70M |
| 55 | GPCR | Structure Therapeutics Inc. | 3.94B | -3.72% | 485,688 | - |
| 56 | VKTX | Viking Therapeutics, Inc. | 3.84B | 0.70% | 1,096,720 | - |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77B | -0.32% | 762,299 | 1.07B |
| 58 | CNTA | Centessa Pharmaceuticals plc | 3.74B | -1.43% | 375,791 | 15.00M |
| 59 | ADMA | ADMA Biologics, Inc. | 3.71B | 1.23% | 1,567,826 | 510.17M |
| 60 | CORT | Corcept Therapeutics Incorporated | 3.56B | -1.06% | 546,864 | 761.41M |
| 61 | LEGN | Legend Biotech Corporation | 3.51B | 0.21% | 776,466 | 909.05M |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.43B | -0.23% | 432,796 | 22.50M |
| 63 | DNLI | Denali Therapeutics Inc. | 3.34B | 6.88% | 1,337,075 | - |
| 64 | DNTH | Dianthus Therapeutics, Inc. | 3.33B | 18.08% | 3,205,162 | 2.04M |
| 65 | ALMS | Alumis Inc. | 3.25B | -2.97% | 1,147,040 | 22.12M |
| 66 | SYRE | Spyre Therapeutics, Inc. | 3.15B | -0.05% | 289,285 | - |
| 67 | TARS | Tarsus Pharmaceuticals, Inc. | 3.14B | 0.85% | 149,724 | 451.36M |
| 68 | IDYA | IDEAYA Biosciences, Inc. | 3.06B | 4.82% | 334,614 | 218.71M |
| 69 | EWTX | Edgewise Therapeutics, Inc. | 3.02B | 1.22% | 513,505 | - |
| 70 | VRDN | Viridian Therapeutics, Inc. | 3.02B | 4.13% | 762,965 | 70.85M |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | 0.67% | 465,053 | 376.07M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.99B | 0.99% | 315,531 | 588.99M |
| 73 | RCUS | Arcus Biosciences, Inc. | 2.85B | 2.85% | 789,229 | 247.00M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.82B | 14.80% | 2,102,799 | - |
| 75 | VERA | Vera Therapeutics, Inc. | 2.72B | -2.28% | 539,008 | - |
| 76 | BEAM | Beam Therapeutics Inc. | 2.67B | 1.36% | 628,956 | 139.74M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.63B | 4.63% | 676,627 | 490.73M |
| 78 | APLS | Apellis Pharmaceuticals, Inc. | 2.53B | -1.30% | 584,835 | 1.00B |
| 79 | WVE | Wave Life Sciences Ltd. | 2.47B | - | 1,370,902 | 42.73M |
| 80 | TLX | Telix Pharmaceuticals Limited | 2.42B | -2.13% | 87,453 | 803.79M |
| 81 | IRON | Disc Medicine, Inc. | 2.39B | 2.17% | 574,329 | - |
| 82 | TNGX | Tango Therapeutics, Inc. | 2.37B | -2.06% | 1,913,790 | 62.38M |
| 83 | IMNM | Immunome, Inc. | 2.34B | -1.62% | 540,265 | 6.94M |
| 84 | IOVA | Iovance Biotherapeutics, Inc. | 2.22B | 5.07% | 18,391,921 | 263.50M |
| 85 | ADPT | Adaptive Biotechnologies Corporation | 2.22B | -3.03% | 1,418,989 | 276.98M |
| 86 | DAWN | Day One Biopharmaceuticals, Inc. | 2.20B | 0.35% | 7,497,388 | 158.18M |
| 87 | SNDX | Syndax Pharmaceuticals, Inc. | 2.17B | 11.46% | 1,544,214 | 172.35M |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.17B | 5.81% | 1,188,963 | 673.00M |
| 89 | GLPG | Galapagos NV | 2.15B | -0.91% | 49,755 | 1.31B |
| 90 | OCUL | Ocular Therapeutix, Inc. | 2.15B | -3.89% | 3,242,542 | 51.95M |
| 91 | STOK | Stoke Therapeutics, Inc. | 2.14B | 5.75% | 353,190 | 205.63M |
| 92 | MAZE | Maze Therapeutics, Inc. | 2.13B | -1.16% | 237,304 | 2.50M |
| 93 | ZLAB | Zai Lab Limited | 2.12B | -3.22% | 255,159 | 460.16M |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.09B | -0.68% | 440,095 | - |
| 95 | AAPG | Ascentage Pharma Group International | 2.05B | -4.97% | 718 | 54.52M |
| 96 | CLDX | Celldex Therapeutics, Inc. | 2.05B | 4.59% | 885,505 | 1.55M |
| 97 | SLNO | Soleno Therapeutics, Inc. | 2.01B | -1.94% | 757,736 | 190.41M |
| 98 | MANE | Veradermics, Incorporated | 1.93B | 6.20% | 262,972 | - |
| 99 | MESO | Mesoblast Limited | 1.91B | -4.54% | 117,712 | 65.38M |
| 100 | NKTR | Nektar Therapeutics | 1.89B | -4.29% | 1,159,900 | 62.60M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.88B | -1.26% | 552,170 | 283.06M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 1.83B | 1.46% | 99,092 | - |
| 103 | SRPT | Sarepta Therapeutics, Inc. | 1.83B | 4.16% | 2,175,044 | 2.20B |
| 104 | TYRA | Tyra Biosciences, Inc. | 1.80B | -4.38% | 627,835 | - |
| 105 | RLAY | Relay Therapeutics, Inc. | 1.80B | 2.02% | 1,466,153 | 15.36M |
| 106 | RXRX | Recursion Pharmaceuticals, Inc. | 1.80B | -1.73% | 8,627,982 | 74.68M |
| 107 | ZYME | Zymeworks Inc. | 1.80B | 1.08% | 493,699 | 105.97M |
| 108 | ELVN | Enliven Therapeutics, Inc. | 1.79B | 1.83% | 183,063 | - |
| 109 | DFTX | Definium Therapeutics, Inc. | 1.77B | 0.51% | 794,625 | - |
| 110 | PHVS | Pharvaris N.V. | 1.69B | 0.69% | 74,546 | - |
| 111 | VCEL | Vericel Corporation | 1.68B | -1.60% | 237,184 | 276.26M |
| 112 | IMCR | Immunocore Holdings plc | 1.67B | 0.30% | 144,050 | 400.02M |
| 113 | NVAX | Novavax, Inc. | 1.67B | 2.91% | 3,903,313 | 1.12B |
| 114 | ANAB | AnaptysBio, Inc. | 1.65B | 3.70% | 186,024 | 234.60M |
| 115 | GLTO | Galecto, Inc. | 1.65B | -5.40% | 170,700 | - |
| 116 | INVA | Innoviva, Inc. | 1.64B | 0.66% | 270,060 | 411.33M |
| 117 | SION | Sionna Therapeutics, Inc. | 1.64B | 1.59% | 162,282 | - |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.63B | 1.27% | 276,544 | 54.03M |
| 119 | NTLA | Intellia Therapeutics, Inc. | 1.62B | 1.79% | 2,203,948 | 67.67M |
| 120 | NBTX | Nanobiotix S.A. | 1.61B | 12.44% | 66,384 | 11.93M |
| 121 | HRMY | Harmony Biosciences Holdings, Inc. | 1.61B | -2.01% | 246,432 | 868.45M |
| 122 | ORKA | Oruka Therapeutics, Inc. | 1.60B | 0.03% | 128,691 | - |
| 123 | NUVB | Nuvation Bio Inc. | 1.59B | 0.87% | 2,973,588 | 62.90M |
| 124 | OCS | Oculis Holding AG | 1.58B | -0.37% | 111,489 | 1.51M |
| 125 | NRIX | Nurix Therapeutics, Inc. | 1.55B | -0.20% | 345,893 | 83.98M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.53B | 0.31% | 1,838,354 | 68.56M |
| 127 | CAPR | Capricor Therapeutics, Inc. | 1.53B | 6.02% | 1,955,022 | 11.13M |
| 128 | GENB | Generate Biomedicines, Inc. | 1.53B | 7.05% | 496,610 | 31.89M |
| 129 | TRVI | Trevi Therapeutics, Inc. | 1.51B | -11.50% | 1,249,240 | - |
| 130 | KOD | Kodiak Sciences Inc. | 1.50B | -2.61% | 283,864 | - |
| 131 | ARDX | Ardelyx, Inc. | 1.49B | -2.10% | 1,884,519 | 407.32M |
| 132 | BHVN | Biohaven Ltd. | 1.46B | -2.47% | 4,204,824 | - |
| 133 | RAPP | Rapport Therapeutics, Inc. | 1.40B | -2.88% | 456,492 | - |
| 134 | GLUE | Monte Rosa Therapeutics, Inc. | 1.39B | -1.74% | 326,466 | 181.54M |
| 135 | ZBIO | Zenas BioPharma, Inc. | 1.37B | 1.07% | 299,642 | 15.00M |
| 136 | ATAI | AtaiBeckley Inc. | 1.35B | 9.73% | 6,303,578 | 3.02M |
| 137 | MBX | MBX Biosciences, Inc. | 1.34B | -7.30% | 279,910 | - |
| 138 | IMTX | Immatics N.V. | 1.32B | - | 102,164 | 56.67M |
| 139 | SVRA | Savara Inc. | 1.32B | 1.33% | 738,624 | - |
| 140 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | -0.54% | 634,726 | - |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.30B | -0.14% | 618,398 | - |
| 142 | OLMA | Olema Pharmaceuticals, Inc. | 1.29B | -23.81% | 9,934,351 | - |
| 143 | EYPT | EyePoint, Inc. | 1.29B | -1.78% | 728,925 | 31.37M |
| 144 | SEPN | Septerna, Inc. | 1.29B | -0.28% | 236,570 | 22.05M |
| 145 | BCAX | Bicara Therapeutics Inc. | 1.25B | 4.49% | 387,998 | - |
| 146 | TSHA | Taysha Gene Therapies, Inc. | 1.25B | -0.33% | 1,310,998 | 6.31M |
| 147 | DBVT | DBV Technologies S.A. | 1.21B | 4.62% | 139,070 | 5.50M |
| 148 | PGEN | Precigen, Inc. | 1.21B | 2.71% | 1,497,338 | 6.31M |
| 149 | IVA | Inventiva S.A. | 1.18B | 1.14% | 151,613 | 19.93M |
| 150 | ORIC | ORIC Pharmaceuticals, Inc. | 1.15B | -16.12% | 2,633,425 | - |
| 151 | QURE | uniQure N.V. | 1.09B | 22.70% | 11,539,894 | 16.10M |
| 152 | AVBP | ArriVent BioPharma, Inc. | 1.09B | 5.16% | 1,051,653 | - |
| 153 | PHAR | Pharming Group N.V. | 1.06B | 1.42% | 4,563 | 362.27M |
| 154 | ABCL | AbCellera Biologics Inc. | 1.05B | - | 1,132,842 | 75.13M |
| 155 | SLS | SELLAS Life Sciences Group, Inc. | 1.03B | 9.22% | 6,048,592 | - |
| 156 | INBX | Inhibrx Biosciences, Inc. | 1.00B | -0.25% | 171,318 | 1.40M |
| 157 | GERN | Geron Corporation | 1.00B | 2.29% | 8,535,507 | 183.88M |
| 158 | AKTS | Aktis Oncology, Inc. | 987.94M | - | 166,238 | 5.56M |
| 159 | GHRS | GH Research PLC | 987.51M | -0.06% | 152,902 | - |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 972.51M | -2.93% | 756,812 | 291.85M |
| 161 | CMPX | Compass Therapeutics, Inc. | 963.47M | -2.90% | 1,012,561 | 850.00K |
| 162 | URGN | UroGen Pharma Ltd. | 942.73M | -5.35% | 460,541 | 109.79M |
| 163 | VALN | Valneva SE | 920.15M | 1.33% | 3,300 | 211.09M |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 909.77M | -2.16% | 471,520 | - |
| 165 | MRVI | Maravai LifeSciences Holdings, Inc. | 903.59M | -0.99% | 1,754,895 | 185.74M |
| 166 | SPRY | ARS Pharmaceuticals, Inc. | 897.55M | 0.22% | 1,027,012 | 84.28M |
| 167 | ABUS | Arbutus Biopharma Corporation | 896.23M | 2.87% | 2,230,178 | 14.61M |
| 168 | SGP | SpyGlass Pharma, Inc. | 895.91M | 0.79% | 62,383 | - |
| 169 | FTRE | Fortrea Holdings Inc. | 878.90M | -2.19% | 960,909 | 2.72B |
| 170 | EVMN | Evommune, Inc. | 873.81M | -8.45% | 144,786 | 13.00M |
| 171 | PHAT | Phathom Pharmaceuticals, Inc. | 863.55M | 2.71% | 340,323 | 175.11M |
| 172 | KALV | KalVista Pharmaceuticals, Inc. | 863.33M | 5.24% | 1,300,204 | 1.43M |
| 173 | XNCR | Xencor, Inc. | 854.40M | 2.92% | 365,068 | 125.58M |
| 174 | MPLT | MapLight Therapeutics, Inc. | 844.46M | 4.54% | 100,308 | - |
| 175 | ARVN | Arvinas, Inc. | 839.49M | -3.49% | 346,890 | 262.60M |
| 176 | CTMX | CytomX Therapeutics, Inc. | 838.71M | 5.77% | 1,307,904 | 113.63M |
| 177 | SANA | Sana Biotechnology, Inc. | 837.96M | -0.32% | 1,924,698 | - |
| 178 | JANX | Janux Therapeutics, Inc. | 830.35M | -1.37% | 521,431 | 10.00M |
| 179 | KURA | Kura Oncology, Inc. | 826.32M | 4.41% | 1,337,675 | 67.48M |
| 180 | EIKN | Eikon Therapeutics, Inc. | 821.64M | 5.84% | 164,325 | - |
| 181 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 817.14M | -2.02% | 84,772 | - |
| 182 | ANNX | Annexon, Inc. | 803.41M | 4.46% | 1,313,465 | - |
| 183 | MNKD | MannKind Corporation | 801.06M | -0.38% | 4,089,276 | 348.97M |
| 184 | OMER | Omeros Corporation | 792.67M | -3.12% | 537,049 | - |
| 185 | DRUG | Bright Minds Biosciences Inc. | 738.16M | 2.66% | 57,733 | - |
| 186 | LXRX | Lexicon Pharmaceuticals, Inc. | 721.77M | -1.17% | 2,349,138 | 49.80M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 720.76M | 2.85% | 122,449 | 107.27M |
| 188 | PRME | Prime Medicine, Inc. | 715.40M | 0.75% | 1,813,826 | 4.63M |
| 189 | REPL | Replimune Group, Inc. | 710.12M | 6.57% | 2,144,759 | - |
| 190 | PROK | ProKidney Corp. | 709.97M | 2.61% | 356,223 | 744.00K |
| 191 | TBPH | Theravance Biopharma, Inc. | 697.25M | 1.40% | 659,374 | 80.33M |
| 192 | JBIO | Jade Biosciences, Inc. | 696.59M | 0.53% | 344,727 | - |
| 193 | AGMB | AgomAb Therapeutics NV | 681.83M | 2.72% | 55,857 | - |
| 194 | ANRO | Alto Neuroscience, Inc. | 661.40M | 2.55% | 175,670 | - |
| 195 | MDXG | MiMedx Group, Inc. | 659.64M | -1.33% | 661,889 | 418.63M |
| 196 | ZURA | Zura Bio Limited | 654.64M | -1.00% | 268,912 | - |
| 197 | TECX | Tectonic Therapeutic, Inc. | 633.34M | -5.97% | 430,603 | - |
| 198 | VOR | Vor Biopharma Inc. | 629.44M | 0.26% | 396,041 | - |
| 199 | SLDB | Solid Biosciences Inc. | 612.37M | 16.44% | 3,082,160 | - |
| 200 | LBRX | LB Pharmaceuticals Inc | 612.36M | 1.79% | 56,204 | - |
| 201 | LRMR | Larimar Therapeutics, Inc. | 597.25M | 5.36% | 1,579,687 | - |
| 202 | MGTX | MeiraGTx Holdings plc | 579.53M | 2.86% | 226,281 | 27.42M |
| 203 | DSGN | Design Therapeutics, Inc. | 577.61M | 0.90% | 87,743 | - |
| 204 | DRTS | Alpha Tau Medical Ltd. | 561.89M | 2.81% | 270,794 | - |
| 205 | YDES | YD Bio Limited | 554.82M | -3.19% | 14,372 | 510.36K |
| 206 | LYEL | Lyell Immunopharma, Inc. | 550.64M | 15.41% | 160,793 | 41.00K |
| 207 | LXEO | Lexeo Therapeutics, Inc. | 545.22M | 9.05% | 1,571,755 | - |
| 208 | VSTM | Verastem, Inc. | 544.58M | -2.82% | 1,112,728 | 30.91M |
| 209 | NMRA | Neumora Therapeutics, Inc. | 539.55M | 5.13% | 641,323 | - |
| 210 | ALLO | Allogene Therapeutics, Inc. | 539.35M | 4.35% | 3,336,196 | 22.00K |
| 211 | RCKT | Rocket Pharmaceuticals, Inc. | 537.42M | 12.24% | 2,986,780 | - |
| 212 | OCGN | Ocugen, Inc. | 534.47M | 1.24% | 4,042,329 | 4.41M |
| 213 | IVVD | Invivyd, Inc. | 532.96M | 5.00% | 1,134,478 | 53.43M |
| 214 | PRTA | Prothena Corporation plc | 527.02M | 2.09% | 354,229 | 9.68M |
| 215 | RGNX | REGENXBIO Inc. | 525.42M | 17.69% | 1,336,514 | 170.44M |
| 216 | ENGN | enGene Holdings Inc. | 521.18M | -10.37% | 556,696 | - |
| 217 | RIGL | Rigel Pharmaceuticals, Inc. | 517.06M | -3.05% | 263,131 | 294.28M |
| 218 | IMMX | Immix Biopharma, Inc. | 510.62M | 4.31% | 654,171 | - |
| 219 | FULC | Fulcrum Therapeutics, Inc. | 509.49M | -6.36% | 660,394 | 80.00M |
| 220 | ADCT | ADC Therapeutics SA | 506.66M | -0.49% | 251,927 | 75.21M |
| 221 | VNDA | Vanda Pharmaceuticals Inc. | 505.96M | 8.49% | 1,352,131 | 216.11M |
| 222 | CRMD | CorMedix Inc. | 505.92M | -0.93% | 1,548,078 | 311.71M |
| 223 | IPSC | Century Therapeutics, Inc. | 503.91M | 9.57% | 1,640,655 | 113.34M |
| 224 | FBRX | Forte Biosciences, Inc. | 503.03M | -1.91% | 44,180 | - |
| 225 | ZVRA | Zevra Therapeutics, Inc. | 499.92M | -1.11% | 493,903 | 84.39M |
| 226 | CTNM | Contineum Therapeutics, Inc. | 496.36M | -4.18% | 111,129 | - |
| 227 | ALT | Altimmune, Inc. | 491.66M | 6.78% | 3,602,195 | 41.00K |
| 228 | AVIR | Atea Pharmaceuticals, Inc. | 486.00M | 3.57% | 627,796 | - |
| 229 | EPRX | Eupraxia Pharmaceuticals Inc. | 481.69M | -2.69% | 77,771 | - |
| 230 | RLMD | Relmada Therapeutics, Inc. | 477.40M | 46.29% | 36,457,544 | - |
| 231 | TENX | Tenax Therapeutics, Inc. | 466.96M | 7.67% | 395,381 | - |
| 232 | KYTX | Kyverna Therapeutics, Inc. | 459.89M | -0.62% | 493,111 | - |
| 233 | ASMB | Assembly Biosciences, Inc. | 458.14M | 2.46% | 47,979 | 37.19M |
| 234 | LCTX | Lineage Cell Therapeutics, Inc. | 455.83M | -1.08% | 750,630 | 14.56M |
| 235 | TRDA | Entrada Therapeutics, Inc. | 447.84M | -1.11% | 118,224 | 25.42M |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 438.16M | 1.30% | 353,197 | 120.00K |
| 237 | BNTC | Benitec Biopharma Inc. | 437.09M | 12.52% | 235,288 | - |
| 238 | AVXL | Anavex Life Sciences Corp. | 436.48M | 1.29% | 435,521 | - |
| 239 | STTK | Shattuck Labs, Inc. | 433.68M | 1.17% | 464,043 | 1.00M |
| 240 | AUTL | Autolus Therapeutics plc | 428.49M | 6.62% | 1,853,325 | 51.13M |
| 241 | UPB | Upstream Bio, Inc. | 426.90M | 3.13% | 328,293 | 2.80M |
| 242 | VTVT | vTv Therapeutics Inc. | 418.18M | -4.83% | 46,868 | 17.00K |
| 243 | NAGE | Niagen Bioscience, Inc. | 412.47M | 1.58% | 1,489,258 | 129.42M |
| 244 | IMMP | Immutep Limited | 408.45M | 1.10% | 113,624 | 5.28M |
| 245 | DMAC | DiaMedica Therapeutics Inc. | 402.91M | -2.46% | 56,125 | - |
| 246 | STRO | Sutro Biopharma, Inc. | 401.17M | -3.20% | 214,339 | 105.65M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 396.98M | 1.03% | 59,841 | 66.98M |
| 248 | NBP | NovaBridge Biosciences | 396.60M | -1.71% | 949,897 | - |
| 249 | PRTC | PureTech Health plc | 395.82M | -1.79% | 3,498 | 6.39M |
| 250 | CBIO | Crescent Biopharma, Inc. | 392.09M | -2.20% | 20,142 | 10.84M |
| 251 | ARMP | Armata Pharmaceuticals, Inc. | 387.73M | 0.47% | 9,783 | 5.05M |
| 252 | ACRS | Aclaris Therapeutics, Inc. | 385.90M | 4.58% | 11,753,778 | 7.83M |
| 253 | PEPG | PepGen Inc. | 380.87M | -2.55% | 316,997 | - |
| 254 | LENZ | LENZ Therapeutics, Inc. | 376.42M | 3.08% | 495,878 | 17.50M |
| 255 | MNPR | Monopar Therapeutics Inc. | 373.89M | -2.88% | 110,147 | - |
| 256 | DNA | Ginkgo Bioworks Holdings, Inc. | 370.78M | -2.00% | 345,541 | 170.16M |
| 257 | CADL | Candel Therapeutics, Inc. | 368.43M | 1.82% | 945,891 | - |
| 258 | CCCC | C4 Therapeutics, Inc. | 365.92M | 23.36% | 4,075,121 | 35.95M |
| 259 | BCYC | Bicycle Therapeutics plc | 364.88M | 1.15% | 500,975 | 28.34M |
| 260 | IMRX | Immuneering Corporation | 359.65M | 4.50% | 695,454 | - |
| 261 | ABSI | Absci Corporation | 359.39M | 0.42% | 2,062,696 | 2.82M |
| 262 | XFOR | X4 Pharmaceuticals, Inc. | 354.99M | 7.98% | 410,121 | 33.98M |
| 263 | NGNE | Neurogene Inc. | 353.32M | 2.89% | 58,567 | 925.00K |
| 264 | AURA | Aura Biosciences, Inc. | 351.81M | -1.07% | 89,341 | - |
| 265 | CLYM | Climb Bio, Inc. | 346.32M | 0.97% | 345,887 | - |
| 266 | CAMP | Camp4 Therapeutics Corporation | 343.71M | 57.62% | 4,115,611 | 3.50M |
| 267 | IRD | Opus Genetics, Inc. | 342.75M | 1.64% | 722,430 | 14.63M |
| 268 | NERV | Minerva Neurosciences, Inc. | 341.44M | 31.28% | 364,134 | - |
| 269 | GLSI | Greenwich LifeSciences, Inc. | 336.67M | 5.24% | 133,438 | - |
| 270 | RZLT | Rezolute, Inc. | 329.27M | 1.93% | 830,214 | - |
| 271 | ANL | Adlai Nortye Ltd. | 326.94M | -0.56% | 70,440 | -1.35M |
| 272 | XOMA | XOMA Royalty Corporation | 320.63M | 3.81% | 161,319 | 47.11M |
| 273 | AVTX | Avalo Therapeutics, Inc. | 320.46M | - | 389,242 | 192.00K |
| 274 | FHTX | Foghorn Therapeutics Inc. | 318.68M | -5.88% | 105,019 | 24.52M |
| 275 | NAUT | Nautilus Biotechnology, Inc. | 312.61M | - | 158,351 | - |
| 276 | PBYI | Puma Biotechnology, Inc. | 308.31M | 0.17% | 193,372 | 228.37M |
| 277 | CABA | Cabaletta Bio, Inc. | 308.05M | 0.95% | 1,044,801 | - |
| 278 | ALDX | Aldeyra Therapeutics, Inc. | 305.43M | 5.73% | 799,167 | - |
| 279 | TARA | Protara Therapeutics, Inc. | 304.91M | -3.56% | 745,070 | - |
| 280 | SLN | Silence Therapeutics plc | 291.20M | -1.04% | 156,653 | 559.00K |
| 281 | CHRS | Coherus Oncology, Inc. | 286.98M | 5.49% | 1,330,773 | 277.73M |
| 282 | ACIU | AC Immune SA | 281.00M | 1.79% | 93,679 | 5.48M |
| 283 | OVID | Ovid Therapeutics Inc. | 278.59M | 12.04% | 6,488,016 | 6.61M |
| 284 | ABEO | Abeona Therapeutics Inc. | 278.00M | 5.77% | 1,418,195 | 400.00K |
| 285 | ENLV | Enlivex Ltd. | 274.18M | 1.32% | 76,566 | - |
| 286 | CLLS | Cellectis S.A. | 273.34M | 1.97% | 119,291 | 82.55M |
| 287 | OABI | OmniAb, Inc. | 272.92M | -0.26% | 198,355 | 18.67M |
| 288 | HELP | Cybin Inc. | 271.19M | 3.24% | 803,939 | - |
| 289 | ALXO | ALX Oncology Holdings Inc. | 267.64M | -7.69% | 448,500 | - |
| 290 | CNTX | Context Therapeutics Inc. | 263.23M | -8.17% | 1,064,634 | - |
| 291 | OBIO | Orchestra BioMed Holdings, Inc. | 258.89M | 6.13% | 75,619 | 2.82M |
| 292 | PRLD | Prelude Therapeutics Incorporated | 257.90M | -3.10% | 195,496 | 10.50M |
| 293 | PALI | Palisade Bio, Inc. | 253.31M | 4.29% | 1,644,875 | - |
| 294 | FENC | Fennec Pharmaceuticals Inc. | 251.03M | -4.55% | 95,272 | 38.79M |
| 295 | IKT | Inhibikase Therapeutics, Inc. | 248.94M | -3.19% | 785,766 | 1.00 |
| 296 | SRZN | Surrozen, Inc. | 244.26M | -3.11% | 42,982 | 3.60M |
| 297 | ALEC | Alector, Inc. | 237.28M | 7.50% | 591,417 | 21.05M |
| 298 | NVCT | Nuvectis Pharma, Inc. | 233.13M | -1.79% | 18,722 | - |
| 299 | CBUS | Cibus, Inc. | 232.39M | 8.86% | 220,812 | 3.79M |
| 300 | CNTN | Canton Strategic Holdings, Inc. | 229.26M | -0.67% | 358,579 | - |
| 301 | ELDN | Eledon Pharmaceuticals, Inc. | 228.53M | 3.59% | 1,742,999 | - |
| 302 | HUMA | Humacyte, Inc. | 227.74M | 6.31% | 5,001,368 | 1.57M |
| 303 | SLGL | Sol-Gel Technologies Ltd. | 225.37M | -0.91% | 30,134 | 18.97M |
| 304 | PLX | Protalix BioTherapeutics, Inc. | 224.78M | 6.68% | 1,050,416 | 61.84M |
| 305 | RNAC | Cartesian Therapeutics, Inc. | 223.63M | 25.55% | 2,516,618 | 2.80M |
| 306 | ACHV | Achieve Life Sciences, Inc. | 223.05M | -1.87% | 194,834 | - |
| 307 | VYGR | Voyager Therapeutics, Inc. | 222.96M | 2.82% | 303,053 | 31.32M |
| 308 | EDIT | Editas Medicine, Inc. | 222.57M | 14.00% | 3,872,148 | 40.52M |
| 309 | PMN | ProMIS Neurosciences, Inc. | 222.04M | 5.81% | 26,545 | - |
| 310 | KROS | Keros Therapeutics, Inc. | 216.89M | -2.65% | 413,082 | 244.06M |
| 311 | MDWD | MediWound Ltd. | 216.19M | -1.17% | 58,431 | 16.96M |
| 312 | GALT | Galectin Therapeutics Inc. | 214.05M | 7.10% | 328,258 | - |
| 313 | TNYA | Tenaya Therapeutics, Inc. | 210.01M | 9.23% | 10,188,328 | - |
| 314 | ARCT | Arcturus Therapeutics Holdings Inc. | 203.22M | 0.56% | 298,796 | 82.03M |
| 315 | ELTX | Elicio Therapeutics, Inc. | 200.90M | -1.15% | 98,460 | - |
| 316 | CGEN | Compugen Ltd. | 199.98M | 1.68% | 159,059 | 72.76M |
| 317 | PRQR | ProQR Therapeutics N.V. | 197.52M | 5.34% | 391,492 | 18.86M |
| 318 | NTHI | NeOnc Technologies Holdings, Inc. | 193.01M | 2.64% | 24,972 | 59.99K |
| 319 | WHWK | Whitehawk Therapeutics, Inc. | 193.00M | 9.21% | 253,944 | 14.38M |
| 320 | CRBU | Caribou Biosciences, Inc. | 188.44M | 7.14% | 1,278,072 | 11.16M |
| 321 | MOLN | Molecular Partners AG | 187.40M | 4.39% | 237 | 856.30K |
| 322 | VXRT | Vaxart, Inc. | 187.29M | 5.63% | 526,546 | 148.20M |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 185.96M | -7.25% | 229,390 | - |
| 324 | NKTX | Nkarta, Inc. | 184.68M | 4.00% | 392,031 | - |
| 325 | KLRS | Kalaris Therapeutics, Inc. | 181.51M | -1.17% | 33,749 | - |
| 326 | SABS | SAB Biotherapeutics, Inc. | 179.72M | -0.40% | 109,174 | 114.70K |
| 327 | HRTX | Heron Therapeutics, Inc. | 178.28M | -2.17% | 979,547 | 154.90M |
| 328 | TLSA | Tiziana Life Sciences Ltd | 176.12M | -0.72% | 58,846 | - |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 176.02M | 18.60% | 360,627 | - |
| 330 | TNXP | Tonix Pharmaceuticals Holding Corp. | 174.00M | 1.12% | 158,708 | 10.30M |
| 331 | MENS | Jyong Biotech Ltd. | 172.64M | 3.94% | 76,958 | - |
| 332 | SGMT | Sagimet Biosciences Inc. | 170.41M | -3.14% | 243,618 | - |
| 333 | PLYX | Polaryx Therapeutics, Inc. | 165.70M | 27.74% | 626,187 | - |
| 334 | MIST | Milestone Pharmaceuticals Inc. | 164.56M | 2.53% | 1,580,618 | - |
| 335 | IMUX | Immunic, Inc. | 161.12M | 0.41% | 1,264,401 | - |
| 336 | RANI | Rani Therapeutics Holdings, Inc. | 157.98M | - | 246,398 | 1.20M |
| 337 | ZNTL | Zentalis Pharmaceuticals, Inc. | 156.70M | 5.45% | 353,520 | 26.87M |
| 338 | KPTI | Karyopharm Therapeutics Inc. | 152.81M | -5.02% | 354,615 | 146.07M |
| 339 | FATE | Fate Therapeutics, Inc. | 151.72M | -1.88% | 970,871 | 6.65M |
| 340 | IPHA | Innate Pharma S.A. | 151.10M | -1.25% | 2,951 | 14.84M |
| 341 | SGMO | Sangamo Therapeutics, Inc. | 148.67M | 5.96% | 3,328,237 | 32.88M |
| 342 | MGNX | MacroGenics, Inc. | 148.34M | 5.16% | 708,255 | 127.63M |
| 343 | CNTB | Connect Biopharma Holdings Limited | 148.14M | 6.85% | 161,804 | 762.00K |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 146.57M | 3.49% | 231,715 | - |
| 345 | ANTX | AN2 Therapeutics, Inc. | 142.49M | 82.46% | 51,451,119 | - |
| 346 | ADAG | Adagene Inc. | 141.39M | 5.63% | 31,972 | 103.20K |
| 347 | ARTV | Artiva Biotherapeutics, Inc. | 137.21M | -2.61% | 87,665 | 251.00K |
| 348 | CRDF | Cardiff Oncology, Inc. | 132.97M | 3.46% | 506,102 | 593.00K |
| 349 | ACOG | Alpha Cognition Inc. | 131.97M | 4.84% | 20,798 | 7.43M |
| 350 | AARD | Aardvark Therapeutics, Inc. | 131.08M | 2.91% | 228,353 | - |
| 351 | ORMP | Oramed Pharmaceuticals Inc. | 128.56M | -1.67% | 80,213 | 2.00M |
| 352 | SPRO | Spero Therapeutics, Inc. | 127.93M | -1.27% | 313,980 | 40.55M |
| 353 | GOSS | Gossamer Bio, Inc. | 123.94M | 6.95% | 5,788,672 | 44.05M |
| 354 | GNLX | Genelux Corporation | 123.78M | 3.14% | 62,102 | 8.00K |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 120.23M | 0.57% | 354,722 | 182.34K |
| 356 | BDTX | Black Diamond Therapeutics, Inc. | 117.93M | -3.73% | 432,198 | 70.00M |
| 357 | DTIL | Precision BioSciences, Inc. | 116.63M | 5.10% | 480,742 | 698.00K |
| 358 | KRRO | Korro Bio, Inc. | 115.83M | 10.02% | 702,053 | 7.37M |
| 359 | GANX | Gain Therapeutics, Inc. | 114.81M | -2.13% | 765,999 | - |
| 360 | ONCY | Oncolytics Biotech Inc. | 112.45M | -1.42% | 1,012,591 | - |
| 361 | COYA | Coya Therapeutics, Inc. | 111.84M | -0.42% | 70,745 | 3.99M |
| 362 | CDXS | Codexis, Inc. | 111.55M | 0.41% | 777,360 | 52.93M |
| 363 | EQ | Equillium, Inc. | 109.61M | 1.69% | 96,083 | 4.39M |
| 364 | AGEN | Agenus Inc. | 106.45M | 5.74% | 298,390 | 106.83M |
| 365 | FBIO | Fortress Biotech, Inc. | 104.60M | 0.90% | 405,303 | 62.30M |
| 366 | BMEA | Biomea Fusion, Inc. | 102.63M | 4.43% | 1,213,319 | - |
| 367 | DWTX | Dogwood Therapeutics, Inc. | 101.55M | 5.54% | 30,954 | - |
| 368 | SAVA | Cassava Sciences, Inc. | 100.72M | 2.71% | 426,405 | - |
| 369 | SEER | Seer, Inc. | 100.43M | - | 415,827 | 16.58M |
| 370 | HURA | TuHURA Biosciences, Inc. | 98.97M | 8.67% | 620,018 | - |
| 371 | TTRX | Turn Therapeutics Inc. | 98.94M | -4.00% | 7,539 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 96.97M | 1.93% | 56,047 | - |
| 373 | VANI | Vivani Medical, Inc. | 92.63M | -0.85% | 75,200 | - |
| 374 | VRCA | Verrica Pharmaceuticals Inc. | 90.82M | 6.97% | 139,621 | 30.83M |
| 375 | CGTX | Cognition Therapeutics, Inc. | 90.04M | -0.97% | 606,679 | - |
| 376 | PYXS | Pyxis Oncology, Inc. | 88.10M | 3.28% | 251,327 | 2.82M |
| 377 | MAIA | MAIA Biotechnology, Inc. | 86.52M | -4.22% | 631,838 | - |
| 378 | OKYO | OKYO Pharma Limited | 85.27M | - | 150,350 | - |
| 379 | PMVP | PMV Pharmaceuticals, Inc. | 85.14M | -2.44% | 559,464 | - |
| 380 | KZIA | Kazia Therapeutics Limited | 84.34M | -6.18% | 46,215 | 1.20M |
| 381 | MCRB | Seres Therapeutics, Inc. | 83.77M | 1.42% | 46,326 | 351.00K |
| 382 | ATYR | aTyr Pharma, Inc. | 83.71M | 3.60% | 1,004,343 | 190.00K |
| 383 | CSBR | Champions Oncology, Inc. | 82.97M | 1.79% | 1,860 | 58.42M |
| 384 | IBIO | iBio, Inc. | 82.56M | -8.43% | 1,127,007 | 300.00K |
| 385 | PLRX | Pliant Therapeutics, Inc. | 80.50M | -1.50% | 234,247 | - |
| 386 | PYPD | PolyPid Ltd. | 79.20M | -0.95% | 33,370 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 76.84M | 2.72% | 725 | 7.41M |
| 388 | ACET | Adicet Bio, Inc. | 75.60M | 2.61% | 64,621 | - |
| 389 | COEP | Coeptis Therapeutics Holdings, Inc. | 74.13M | -1.06% | 114,748 | 501.00K |
| 390 | GUTS | Fractyl Health, Inc. | 74.03M | 0.56% | 1,279,881 | 3.00K |
| 391 | QTTB | Q32 Bio Inc. | 72.58M | 10.53% | 190,096 | - |
| 392 | CING | Cingulate Inc. | 71.16M | 6.22% | 336,711 | - |
| 393 | XBIT | XBiotech Inc. | 70.79M | -1.19% | 23,125 | - |
| 394 | ACTU | Actuate Therapeutics, Inc. | 69.73M | 4.90% | 68,421 | - |
| 395 | TCRX | TScan Therapeutics, Inc. | 69.42M | 8.93% | 1,000,355 | 10.33M |
| 396 | ANVS | Annovis Bio, Inc. | 67.58M | 2.41% | 315,071 | - |
| 397 | MNOV | MediciNova, Inc. | 66.94M | - | 58,626 | 409.66K |
| 398 | SPRB | Spruce Biosciences, Inc. | 66.58M | 11.33% | 61,192 | 697.00K |
| 399 | IBO | Impact BioMedical Inc. | 65.71M | -6.59% | 1,018,884 | 25.00K |
| 400 | IFRX | InflaRx N.V. | 64.68M | -1.57% | 128,376 | 73.73K |
| 401 | IMA | ImageneBio, Inc. | 62.63M | 0.68% | 12,174 | 800.00K |
| 402 | MREO | Mereo BioPharma Group plc | 62.17M | -0.86% | 657,730 | 500.00K |
| 403 | EXOZ | eXoZymes, Inc. | 61.49M | 0.10% | 1,631 | -700.00 |
| 404 | GRCE | Grace Therapeutics, Inc. | 61.43M | 2.85% | 208,807 | - |
| 405 | ENTX | Entera Bio Ltd. | 61.22M | 6.80% | 51,742 | 124.00K |
| 406 | ATHE | Alterity Therapeutics Limited | 61.05M | 3.79% | 5,118 | 4.43M |
| 407 | OSTX | OS Therapies Incorporated | 60.57M | 9.55% | 1,443,982 | - |
| 408 | TIL | Instil Bio, Inc. | 60.19M | 0.06% | 21,794 | - |
| 409 | BYSI | BeyondSpring Inc. | 59.63M | - | 20,187 | 1.88M |
| 410 | NRXS | NeurAxis, Inc. | 59.28M | -2.54% | 52,380 | 3.36M |
| 411 | MGX | Metagenomi Therapeutics, Inc. | 58.95M | 6.08% | 193,954 | 25.21M |
| 412 | ICCC | ImmuCell Corporation | 57.98M | -2.88% | 12,342 | 27.64M |
| 413 | RLYB | Rallybio Corporation | 57.76M | 0.09% | 52,574 | 674.00K |
| 414 | EDSA | Edesa Biotech, Inc. | 57.44M | 5.52% | 5,313,742 | - |
| 415 | LONA | LeonaBio, Inc. | 55.83M | 12.83% | 20,759 | - |
| 416 | NRXP | NRx Pharmaceuticals, Inc. | 53.86M | -0.59% | 524,152 | 242.00K |
| 417 | RADX | Radiopharm Theranostics Limited | 52.22M | -1.80% | 99,259 | 10.86M |
| 418 | PSTV | Plus Therapeutics, Inc. | 52.17M | 2.15% | 2,762,337 | 5.26M |
| 419 | ACRV | Acrivon Therapeutics, Inc. | 51.75M | 5.81% | 623,815 | - |
| 420 | KZR | Kezar Life Sciences, Inc. | 51.70M | 1.73% | 5,026 | - |
| 421 | ATRA | Atara Biotherapeutics, Inc. | 51.41M | 37.91% | 2,740,349 | 151.93M |
| 422 | NTRB | Nutriband Inc. | 50.33M | -5.05% | 1,404 | 2.28M |
| 423 | HYFT | MindWalk Holdings Corp. | 49.73M | -4.05% | 496,198 | 19.02M |
| 424 | INKT | MiNK Therapeutics, Inc. | 48.40M | 0.29% | 4,632 | - |
| 425 | KLTO | Klotho Neurosciences, Inc. | 46.74M | -5.70% | 1,769,891 | - |
| 426 | LPCN | Lipocine Inc. | 45.47M | 0.74% | 9,593 | 4.32M |
| 427 | ESLA | Estrella Immunopharma, Inc. | 45.40M | 0.93% | 46,974 | - |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 45.19M | 5.16% | 38,971 | - |
| 429 | LSTA | Lisata Therapeutics, Inc. | 44.41M | 20.45% | 389,261 | 1.07M |
| 430 | CRVO | CervoMed Inc. | 44.37M | 16.67% | 197,506 | 6.16M |
| 431 | NXTC | NextCure, Inc. | 43.82M | 0.89% | 7,162 | - |
| 432 | OKUR | OnKure Therapeutics, Inc. | 43.76M | 5.90% | 242,120 | - |
| 433 | APLM | Apollomics, Inc. | 43.16M | 0.25% | 5,492 | 6.93M |
| 434 | LITS | Lite Strategy, Inc. | 42.54M | 2.63% | 456,931 | - |
| 435 | ALGS | Aligos Therapeutics, Inc. | 42.08M | -2.03% | 28,758 | 2.19M |
| 436 | XLO | Xilio Therapeutics, Inc. | 41.85M | 7.49% | 235,692 | 31.80M |
| 437 | PTN | Palatin Technologies, Inc. | 40.78M | -4.79% | 7,957 | 8.96M |
| 438 | VERU | Veru Inc. | 39.64M | - | 28,561 | 16.89M |
| 439 | ATOS | Atossa Therapeutics, Inc. | 38.67M | -0.88% | 87,145 | - |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 37.44M | - | 26,006 | 90.00K |
| 441 | PDSB | PDS Biotechnology Corporation | 37.24M | 1.13% | 138,766 | - |
| 442 | TVRD | Tvardi Therapeutics, Inc. | 36.87M | - | 14,209 | - |
| 443 | SNSE | Sensei Biotherapeutics, Inc. | 36.40M | -4.12% | 70,527 | - |
| 444 | JSPR | Jasper Therapeutics, Inc. | 36.38M | -5.80% | 115,194 | - |
| 445 | CELU | Celularity Inc. | 36.34M | 4.13% | 15,800 | 40.58M |
| 446 | ABVC | ABVC BioPharma, Inc. | 36.32M | 9.70% | 66,119 | 797.92K |
| 447 | OTLK | Outlook Therapeutics, Inc. | 36.11M | 5.00% | 1,123,503 | 205.70K |
| 448 | HOWL | Werewolf Therapeutics, Inc. | 33.80M | 10.21% | 675,303 | 1.14M |
| 449 | PLUR | Pluri Inc. | 33.77M | 2.44% | 4,240 | 1.34M |
| 450 | INMB | INmune Bio Inc. | 33.36M | -5.64% | 772,573 | 50.00K |
| 451 | CVM | CEL-SCI Corporation | 32.05M | 0.51% | 13,706 | - |
| 452 | RNTX | Rein Therapeutics Inc. | 31.55M | 0.01% | 20,644 | - |
| 453 | TPST | Tempest Therapeutics, Inc. | 31.55M | 1.30% | 50,743 | - |
| 454 | NBY | NovaBay Pharmaceuticals, Inc. | 30.57M | -15.83% | 249,310 | 10.30M |
| 455 | TVGN | Tevogen Bio Holdings Inc. | 29.96M | 1.23% | 48,845 | - |
| 456 | KYNB | Kyntra Bio, Inc. | 29.55M | 6.80% | 47,487 | 8.30M |
| 457 | RNXT | RenovoRx, Inc. | 29.32M | 1.25% | 106,420 | 928.00K |
| 458 | LTRN | Lantern Pharma Inc. | 29.20M | -3.31% | 39,464 | - |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 28.73M | -0.66% | 174,898 | - |
| 460 | DYAI | Dyadic International, Inc. | 28.26M | 1.75% | 43,244 | 3.34M |
| 461 | HYPD | Hyperion DeFi, Inc. | 27.80M | 6.43% | 343,633 | 345.32K |
| 462 | BCTX | BriaCell Therapeutics Corp. | 27.53M | -0.26% | 161,285 | - |
| 463 | FBLG | FibroBiologics, Inc. | 27.15M | -7.66% | 673,648 | - |
| 464 | IGC | IGC Pharma, Inc. | 27.12M | -1.01% | 262,861 | 1.11M |
| 465 | AEON | AEON Biopharma, Inc. | 26.57M | -0.94% | 74,615 | - |
| 466 | CUE | Cue Biopharma, Inc. | 26.46M | -3.28% | 180,446 | 7.10M |
| 467 | XCUR | Exicure, Inc. | 26.07M | -1.44% | 4,817 | 500.00K |
| 468 | SNTI | Senti Biosciences, Inc. | 25.91M | 2.12% | 189,356 | - |
| 469 | PASG | Passage Bio, Inc. | 25.73M | -4.52% | 7,877 | - |
| 470 | EVAX | Evaxion A/S | 25.69M | -4.34% | 24,868 | 7.53M |
| 471 | BOLD | Boundless Bio, Inc. | 25.63M | 1.33% | 45,790 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 25.18M | 8.10% | 43,845 | 14.99M |
| 473 | MRKR | Marker Therapeutics, Inc. | 24.68M | 7.25% | 115,713 | 4.69M |
| 474 | BRNS | Barinthus Biotherapeutics plc | 24.50M | -0.50% | 7,432 | 14.97M |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 23.71M | -1.51% | 368,188 | 789.00K |
| 476 | SKYE | Skye Bioscience, Inc. | 23.08M | -0.06% | 151,705 | - |
| 477 | LIXT | Lixte Biotechnology Holdings, Inc. | 22.00M | 3.48% | 25,897 | - |
| 478 | DARE | Daré Bioscience, Inc. | 21.51M | -1.63% | 38,072 | -57.13K |
| 479 | NNVC | NanoViricides, Inc. | 21.41M | 3.31% | 54,293 | - |
| 480 | PLRZ | Polyrizon Ltd. | 20.88M | -0.08% | 4,648 | - |
| 481 | IOBT | IO Biotech, Inc. | 20.12M | -6.96% | 1,171,989 | - |
| 482 | ALLR | Allarity Therapeutics, Inc. | 20.02M | 0.40% | 629,491 | - |
| 483 | GNTA | Genenta Science S.p.A. | 19.73M | -2.08% | 12,991 | - |
| 484 | VYNE | VYNE Therapeutics Inc. | 19.57M | -1.29% | 55,295 | 570.00K |
| 485 | INTS | Intensity Therapeutics, Inc. | 19.49M | -3.27% | 14,347 | - |
| 486 | CVKD | Cadrenal Therapeutics, Inc. | 18.88M | -2.48% | 17,130 | - |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 18.12M | -3.02% | 223,412 | 3.94M |
| 488 | LEXX | Lexaria Bioscience Corp. | 17.92M | -13.13% | 164,261 | 522.00K |
| 489 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 17.60M | -15.66% | 362,844 | - |
| 490 | INAB | IN8bio, Inc. | 17.53M | 4.36% | 41,801 | - |
| 491 | KTTA | Pasithea Therapeutics Corp. | 17.38M | -5.52% | 52,697 | - |
| 492 | SER | Serina Therapeutics, Inc. | 16.51M | 0.04% | 53,271 | 116.00K |
| 493 | HOTH | Hoth Therapeutics, Inc. | 15.30M | -0.65% | 115,227 | - |
| 494 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.25M | -2.36% | 10,882 | - |
| 495 | COCP | Cocrystal Pharma, Inc. | 14.06M | 0.99% | 11,478 | - |
| 496 | JUNS | Jupiter Neurosciences, Inc. | 13.77M | 3.36% | 97,322 | - |
| 497 | CRIS | Curis, Inc. | 13.62M | 0.51% | 29,897 | 11.65M |
| 498 | GTBP | GT Biopharma, Inc. | 13.41M | -9.42% | 665,848 | - |
| 499 | QNTM | Quantum BioPharma Ltd. | 13.38M | -2.86% | 20,989 | - |
| 500 | BCDA | BioCardia, Inc. | 13.32M | 6.36% | 141,263 | 3.00K |
| 501 | BCAB | BioAtla, Inc. | 13.29M | 6.67% | 976,996 | 11.00M |
| 502 | TRAW | Traws Pharma, Inc. | 13.18M | 3.12% | 24,860 | 2.85M |
| 503 | KAPA | Kairos Pharma, Ltd. | 13.14M | 0.21% | 81,696 | - |
| 504 | NCEL | NewcelX Ltd. | 12.74M | 0.90% | 94,424 | - |
| 505 | BLRX | BioLineRx Ltd. | 12.68M | 0.47% | 19,662 | 12.74M |
| 506 | OSRH | OSR Holdings, Inc. | 12.66M | -3.97% | 900,088 | -90.52K |
| 507 | PHIO | Phio Pharmaceuticals Corp. | 12.38M | -0.86% | 191,764 | - |
| 508 | CMMB | Chemomab Therapeutics Ltd. | 12.00M | 3.72% | 23,729 | - |
| 509 | SNGX | Soligenix, Inc. | 11.90M | -0.83% | 69,593 | 2.34K |
| 510 | CLRB | Cellectar Biosciences, Inc. | 11.70M | - | 43,188 | - |
| 511 | GDTC | CytoMed Therapeutics Limited | 11.66M | -3.81% | 6,121 | 573.19K |
| 512 | PHGE | BiomX Inc. | 11.47M | 5.73% | 83,089 | - |
| 513 | AKTX | Akari Therapeutics, Plc | 11.28M | -0.84% | 55,417 | - |
| 514 | CALC | CalciMedica, Inc. | 11.22M | -1.98% | 211,204 | - |
| 515 | LGVN | Longeveron Inc. | 11.01M | 6.68% | 175,828 | 1.44M |
| 516 | IMNN | Imunon, Inc. | 10.90M | -1.08% | 5,873 | - |
| 517 | LIMN | Liminatus Pharma, Inc. | 10.43M | 0.09% | 572,955 | - |
| 518 | MBRX | Moleculin Biotech, Inc. | 10.26M | - | 96,177 | - |
| 519 | BIVI | BioVie Inc. | 10.10M | -1.47% | 33,036 | - |
| 520 | CLGN | CollPlant Biotechnologies Ltd. | 9.33M | 6.94% | 4,917 | 2.48M |
| 521 | ICU | SeaStar Medical Holding Corporation | 9.30M | 2.38% | 24,560 | 881.00K |
| 522 | ITRM | Iterum Therapeutics plc | 8.66M | -0.97% | 438,726 | 390.00K |
| 523 | NCNA | NuCana plc | 8.49M | -5.56% | 40,798 | - |
| 524 | RNAZ | TransCode Therapeutics, Inc. | 8.44M | -4.17% | 5,861 | - |
| 525 | TOVX | Theriva Biologics, Inc. | 8.36M | 0.83% | 693,847 | - |
| 526 | CDIO | Cardio Diagnostics Holdings, Inc. | 8.07M | -16.60% | 395,505 | 15.78K |
| 527 | ALZN | Alzamend Neuro, Inc. | 8.03M | 6.56% | 71,198 | - |
| 528 | BOLT | Bolt Biotherapeutics, Inc. | 7.98M | -3.26% | 39,597 | 5.20M |
| 529 | TCRT | Alaunos Therapeutics, Inc. | 7.83M | -2.77% | 5,404 | 6.00K |
| 530 | KPRX | Kiora Pharmaceuticals, Inc. | 7.67M | 5.56% | 28,979 | 20.00K |
| 531 | ERNA | Ernexa Therapeutics Inc. | 7.63M | -1.16% | 428,318 | 1,000.00 |
| 532 | PMCB | PharmaCyte Biotech, Inc. | 7.62M | -5.71% | 74,282 | - |
| 533 | ADXN | Addex Therapeutics Ltd | 7.49M | -2.79% | 496 | 198.82K |
| 534 | PULM | Pulmatrix, Inc. | 7.38M | - | 36,700 | 3.00K |
| 535 | IMRN | Immuron Limited | 7.33M | -2.81% | 29,267 | 4.99M |
| 536 | KALA | KALA BIO, Inc. | 7.31M | -6.98% | 1,004,270 | - |
| 537 | EVGN | Evogene Ltd. | 6.93M | -2.21% | 20,075 | 8.02M |
| 538 | GRDX | GridAI Technologies Corp. | 6.93M | -6.36% | 29,668 | - |
| 539 | CELZ | Creative Medical Technology Holdings, Inc. | 6.78M | 3.19% | 24,752 | 6.00K |
| 540 | APVO | Aptevo Therapeutics Inc. | 6.52M | 2.16% | 6,251 | - |
| 541 | XTLB | XTL Biopharmaceuticals Ltd. | 6.43M | -1.11% | 8,987 | 968.00K |
| 542 | CANF | Can-Fite BioPharma Ltd. | 6.38M | -12.95% | 217,648 | 560.00K |
| 543 | APM | Aptorum Group Limited | 6.35M | -2.49% | 10,434 | - |
| 544 | MBIO | Mustang Bio, Inc. | 6.35M | -2.93% | 14,489 | - |
| 545 | PCSA | Processa Pharmaceuticals, Inc. | 6.32M | -1.41% | 4,766 | - |
| 546 | MLEC | Moolec Science SA | 6.24M | -8.02% | 153,676 | 7.83M |
| 547 | APRE | Aprea Therapeutics, Inc. | 6.14M | -2.50% | 62,242 | 488.24K |
| 548 | QNCX | Quince Therapeutics, Inc. | 6.02M | 5.67% | 16,887,201 | - |
| 549 | PPBT | Purple Biotech Ltd | 6.02M | -8.68% | 9,294 | - |
| 550 | ASBP | Aspire Biopharma Holdings, Inc. | 5.98M | 2.59% | 69,966 | 1.94K |
| 551 | PBM | Psyence Biomedical Ltd. | 5.76M | - | 10,161 | - |
| 552 | SLXN | Silexion Therapeutics Corp | 5.53M | 2.31% | 36,762 | - |
| 553 | CYCN | Cyclerion Therapeutics, Inc. | 5.48M | 2.13% | 41,186 | 2.86M |
| 554 | XBIO | Xenetic Biosciences, Inc. | 5.25M | - | 4,661 | 2.86M |
| 555 | MTVA | MetaVia Inc. | 5.13M | 3.23% | 51,165 | - |
| 556 | BRTX | BioRestorative Therapies, Inc. | 5.12M | 12.26% | 2,046,626 | 383.40K |
| 557 | GOVX | GeoVax Labs, Inc. | 4.94M | 5.03% | 60,200 | 3.35M |
| 558 | VIVS | VivoSim Labs, Inc. | 4.80M | 0.55% | 14,007 | 142.00K |
| 559 | BGMS | Bio Green Med Solution, Inc. | 4.76M | 2.21% | 10,808 | 81.00K |
| 560 | REVB | Revelation Biosciences, Inc. | 4.72M | -1.55% | 36,545 | - |
| 561 | LNAI | Lunai Bioworks Inc. | 4.64M | -17.44% | 613,556 | - |
| 562 | GNPX | Genprex, Inc. | 4.59M | 1.54% | 365,998 | - |
| 563 | DCOY | Decoy Therapeutics Inc. | 4.56M | 13.17% | 34,473 | - |
| 564 | ACXP | Acurx Pharmaceuticals, Inc. | 4.38M | 27.41% | 1,882,748 | - |
| 565 | SILO | Silo Pharma, Inc. | 4.37M | 0.18% | 138,078 | 72.10K |
| 566 | GLMD | Galmed Pharmaceuticals Ltd. | 4.22M | -2.82% | 9,592 | - |
| 567 | INDP | Indaptus Therapeutics, Inc. | 4.09M | -1.35% | 29,632 | - |
| 568 | OGEN | Oragenics, Inc. | 4.03M | 5.09% | 229,199 | - |
| 569 | MTNB | Matinas BioPharma Holdings, Inc. | 3.84M | -0.37% | 4,897 | - |
| 570 | HCWB | HCW Biologics Inc. | 3.57M | 0.14% | 12,225 | 422.03K |
| 571 | GRI | GRI Bio, Inc. | 3.45M | -6.82% | 25,373 | - |
| 572 | SPRC | SciSparc Ltd. | 3.26M | 3.39% | 29,160 | 1.31M |
| 573 | AZTR | Azitra, Inc. | 3.17M | 8.65% | 2,985,507 | 7.50K |
| 574 | XRTX | XORTX Therapeutics Inc. | 3.07M | -1.86% | 54,782 | - |
| 575 | DRMA | Dermata Therapeutics, Inc. | 3.05M | 2.40% | 144,013 | - |
| 576 | ARTL | Artelo Biosciences, Inc. | 2.74M | 13.15% | 188,766 | - |
| 577 | ENVB | Enveric Biosciences, Inc. | 2.70M | -0.26% | 26,582 | - |
| 578 | CLDI | Calidi Biotherapeutics, Inc. | 2.68M | -1.25% | 649,664 | - |
| 579 | PPCB | Propanc Biopharma, Inc. | 2.63M | -1.83% | 449,529 | - |
| 580 | SCNI | Scinai Immunotherapeutics Ltd. | 2.57M | -5.13% | 20,214 | 1.15M |
| 581 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.54M | -3.90% | 41,731 | 1.36M |
| 582 | ELAB | PMGC Holdings Inc. | 2.48M | 3.00% | 131,913 | 285.95K |
| 583 | LYRA | Lyra Therapeutics, Inc. | 2.27M | 0.13% | 6,179 | 600.00K |
| 584 | JAGX | Jaguar Health, Inc. | 2.21M | -17.53% | 1,045,383 | 11.79M |
| 585 | BBLG | Bone Biologics Corporation | 2.19M | -4.69% | 11,189 | - |
| 586 | ADIL | Adial Pharmaceuticals, Inc. | 1.98M | -2.63% | 55,892 | - |
| 587 | CDT | CDT Equity Inc. | 1.91M | -1.90% | 34,590 | - |
| 588 | ENSC | Ensysce Biosciences, Inc. | 1.89M | -4.95% | 246,093 | 4.49M |
| 589 | CMND | Clearmind Medicine Inc. | 1.87M | -8.77% | 57,255 | - |
| 590 | CNSP | CNS Pharmaceuticals, Inc. | 1.82M | - | 13,981 | - |
| 591 | VRAX | Virax Biolabs Group Limited | 1.61M | 1.40% | 75,230 | 2.99K |
| 592 | BDRX | Biodexa Pharmaceuticals Plc | 781.08K | 2.78% | 34,197 | 104.90K |
| 593 | ONCO | Onconetix, Inc. | 761.96K | 0.41% | 156,278 | 1.22M |
| 594 | ADTX | Aditxt, Inc. | 743.71K | -10.06% | 213,536 | 5.95K |